KALA BIO, Inc.
KALA
$5.10
$0.050.99%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -12.27% | -10.83% | -13.84% | -26.76% | -54.72% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -3.80% | 3.27% | 3.46% | -4.97% | -35.24% |
| Operating Income | 3.80% | -3.27% | -3.46% | 4.04% | 32.54% |
| Income Before Tax | 9.86% | 8.74% | 16.06% | -348.22% | -50.18% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 9.86% | 8.74% | 16.06% | -348.22% | -50.18% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 9.86% | 8.74% | 16.06% | -348.22% | -50.18% |
| EBIT | 3.80% | -3.27% | -3.46% | 4.04% | 32.54% |
| EBITDA | 3.75% | -3.41% | -3.63% | 3.82% | 32.51% |
| EPS Basic | 45.57% | 38.50% | 45.13% | -17,986.92% | -4.64% |
| Normalized Basic EPS | 42.81% | 33.30% | 49.78% | 52.58% | 66.95% |
| EPS Diluted | 45.57% | 38.51% | 45.15% | -18,577.11% | -3.54% |
| Normalized Diluted EPS | 42.81% | 33.30% | 49.78% | 52.45% | 66.89% |
| Average Basic Shares Outstanding | 78.70% | 56.03% | 52.97% | 46.76% | 56.98% |
| Average Diluted Shares Outstanding | 78.70% | 56.03% | 52.97% | 46.54% | 56.71% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |